Pathophysiology
Parvovirus B19, commonly detected in human heart tissue samples via endomyocardial biopsy, can persist in the host, causing prolonged cardiomyocyte injury and contributing to cardiac muscle remodeling [PMID:37775826].
Epidemiology
This review highlights that more than 100 countries and territories lack a single cardiac surgeon, significantly affecting the global burden and management of viral cardiovascular diseases [PMID:39049768].
Diagnosis
Endomyocardial biopsy combined with molecular detection methods, such as identifying the Parvovirus B19 genome, is crucial for diagnosing viral myocarditis and understanding the specific viral etiology [PMID:37775826].
Management
The paper underscores the critical shortage of cardiac surgical resources in endemic regions, emphasizing the need for improved access to cardiac surgical care for patients with viral cardiovascular conditions [PMID:39049768].
Complications
The review points out that the surgical consequences of neglected viral cardiovascular diseases are poorly described, indicating a need for better understanding and management strategies in resource-limited settings [PMID:39049768].
Viral persistence, particularly Parvovirus B19, in cardiac tissue can contribute to or exacerbate cardiac symptoms, potentially resulting in severe cardiac distress and patient mortality if not addressed [PMID:37775826].
References
1 Gomes Z, Lee GS, Mesfin S, Rocha R, Vervoort D. Viral cardiovascular surgical diseases: global burdens, challenges and opportunities. Future cardiology 2024. link 2 Kloc A, Campbell KS, Espinoza YAU. Detection of Parvovirus B19 genome in human heart tissue samples. BMC research notes 2023. link
2 papers cited of 3 indexed.